Ozempic 0.25mg

Ozempic® 0.25 mg is a once-weekly injectable medicine designed to help adults with type 2 diabetes improve blood sugar control, while also supporting weight management under medical supervision.

🌟 Product Overview

• Name: Ozempic® (semaglutide)
• Strength: 0.25 mg solution for injection
• Form: Pre-filled pen for subcutaneous use
• Class: GLP-1 (Glucagon-Like Peptide-1) receptor agonist

💉 Key Features

• Starter Dose: The 0.25 mg strength is typically used as an initial dose for the first 4 weeks of therapy to help the body adjust before moving to higher maintenance doses.
• Mechanism of Action: Mimics the natural GLP-1 hormone, stimulating insulin release when blood sugar is high, reducing glucagon secretion, and slowing gastric emptying to improve glycemic control.
• Administration: Injected once weekly under the skin (abdomen, thigh, or upper arm) using a simple pre-filled pen.
• Convenience: Ready-to-use pen with dose markings, designed for ease of use and minimal preparation.

⚕️ Indications

• Primary Use: Treatment of adults with type 2 diabetes mellitus, in combination with diet and exercise, to lower blood sugar levels.
• Additional Benefit: May aid in weight reduction, though it is not primarily indicated as a weight-loss drug.

⚠️ Important Safety Information

• Boxed Warning: In animal studies, semaglutide has been associated with thyroid C-cell tumors. Ozempic is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation.
• Precautions: Not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Use with caution in patients with pancreatitis history.

📦 Packaging

• Supplied as a pre-filled pen delivering doses of 0.25 mg or 0.5 mg, depending on treatment stage.
• Each pen contains multiple doses, stored refrigerated until first use.